Skip to content

Analysis of the effect of the percutaneous coronary intervention (catheter-based therapy) on cardiopulmonary exercise test in patients with effort angina

Analysis of the effect of the percutaneous coronary intervention on cardiopulmonary exercise test in patients with effort angina - Analysis of the percutaneous coronary intervention on cardiopulmonary exercise test

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000047773
Enrollment
50
Registered
2022-06-20
Start date
2022-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effort angina

Interventions

Cardiopulmonary exercise tests are scheduled as non-invasive evaluations for patients whose effort angina is suspected. The method of exercise load is a warm-up of 4 minutes at rest and 4 minutes of 1

Sponsors

Sakakibara Heart Institute, Department of Cardiology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients suspected of exertional angina by medical interview, 12-leads electrocardiogram, chest X-ray, transthoracic echocardiography.

Exclusion criteria

Exclusion criteria: Cases with residual lesions, coronary artery bypass surgery, and heart failure symptom of NYHA functional classification II or higher are excluded. In addition, cases with moderate or higher valvular disease, cardiomyopathy, chronic atrial fibrillation or flatter, permanent pacemaker or implantable defibrillator, and lung disease are excluded.

Design outcomes

Primary

MeasureTime frame
The primary endpoint was defined as the changes of VO2/WR among the ischemia and control (non-ischemia) groups. The cardiopulmonary tests were scheduled before and within 3 months after (within 3 months) of the percutaneous coronary intervention.

Secondary

MeasureTime frame
The secondary endpoint was defined as the changes of VO2, VCO2, AT, Peak VO2, T1/2, VO2/HR, R, VE/VO2, VE/VCO2, and VE vs. VCO2 slope among the ischemia and control (non-ischemia) groups. The cardiopulmonary tests were scheduled before and after (within 3 months) of the percutaneous coronary intervention.

Countries

Japan

Contacts

Public ContactTakashi Hiruma

Sakakibara Heart Institute Department of cardiology

th2011tf@gmail.com042-314-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026